• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Signal Transduct Target Ther . Infection with SARS-CoV-2 can cause pancreatic impairment

tetano

Editor, Senior Moderator
Signal Transduct Target Ther


. 2024 Apr 12;9(1):98.
doi: 10.1038/s41392-024-01796-2. Infection with SARS-CoV-2 can cause pancreatic impairment

Wei Deng[SUP] #[/SUP][SUP] 1 [/SUP], Linlin Bao[SUP] #[/SUP][SUP] 1 [/SUP], Zhiqi Song[SUP] #[/SUP][SUP] 1 [/SUP], Ling Zhang[SUP] #[/SUP][SUP] 1 [/SUP], Pin Yu[SUP] #[/SUP][SUP] 1 [/SUP], Yanfeng Xu[SUP] 1 [/SUP], Jue Wang[SUP] 2 3 [/SUP], Wenjie Zhao[SUP] 1 [/SUP], Xiuqin Zhang[SUP] 2 3 [/SUP], Yunlin Han[SUP] 1 [/SUP], Yanhong Li[SUP] 1 [/SUP], Jiangning Liu[SUP] 1 [/SUP], Qi Lv[SUP] 1 [/SUP], Xujian Liang[SUP] 1 [/SUP], Fengdi Li[SUP] 1 [/SUP], Feifei Qi[SUP] 1 [/SUP], Ran Deng[SUP] 1 [/SUP], Siyuan Wang[SUP] 1 [/SUP], Yibai Xiong[SUP] 1 [/SUP], Ruiping Xiao[SUP] 4 5 6 [/SUP], Hongyang Wang[SUP] 7 8 9 [/SUP], Chuan Qin[SUP] 10 11 12 [/SUP]



Affiliations
Abstract

Evidence suggests associations between COVID-19 patients or vaccines and glycometabolic dysfunction and an even higher risk of the occurrence of diabetes. Herein, we retrospectively analyzed pancreatic lesions in autopsy tissues from 67 SARS-CoV-2 infected non-human primates (NHPs) models and 121 vaccinated and infected NHPs from 2020 to 2023 and COVID-19 patients. Multi-label immunofluorescence revealed direct infection of both exocrine and endocrine pancreatic cells by the virus in NHPs and humans. Minor and limited phenotypic and histopathological changes were observed in adult models. Systemic proteomics and metabolomics results indicated metabolic disorders, mainly enriched in insulin resistance pathways, in infected adult NHPs, along with elevated fasting C-peptide and C-peptide/glucose ratio levels. Furthermore, in elder COVID-19 NHPs, SARS-CoV-2 infection causes loss of beta (β) cells and lower expressed-insulin in situ characterized by islet amyloidosis and necrosis, activation of α-SMA and aggravated fibrosis consisting of lower collagen in serum, an increase of pancreatic inflammation and stress markers, ICAM-1 and G3BP1, along with more severe glycometabolic dysfunction. In contrast, vaccination maintained glucose homeostasis by activating insulin receptor α and insulin receptor β. Overall, the cumulative risk of diabetes post-COVID-19 is closely tied to age, suggesting more attention should be paid to blood sugar management in elderly COVID-19 patients.


 
Back
Top Bottom